FNY Investment Advisers, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 91 filers reported holding ADMA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 4.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
FNY Investment Advisers, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q1 2023$0
-100.0%
75
-98.5%
0.00%
-100.0%
Q4 2022$195,097
+6696.0%
0.03%
Q3 2022$0750.0%0.00%
Q2 2022$0750.0%0.00%
Q1 2022$0750.0%0.00%
Q4 2021$0750.0%0.00%
Q3 2021$0750.0%0.00%
Q2 2021$0750.0%0.00%
Q1 2021$0750.0%0.00%
Q4 2020$0750.0%0.00%
Q3 2020$0750.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital LLC 3,608,171$8,624,0002.44%
Broadfin Capital, LLC 4,226,077$10,100,0001.33%
MORGENS WATERFALL VINTIADIS & CO INC 400,000$956,0000.85%
Consonance Capital Management LP 4,588,352$10,966,0000.81%
Perceptive Advisors 6,521,102$14,542,0000.55%
Diag Capital Management, LP 182,100$435,0000.50%
683 Capital Management, LLC 805,000$1,924,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$120,0000.03%
AVANTAX ADVISORY SERVICES, INC. 65,050$156,0000.03%
PURA VIDA INVESTMENTS, LLC 37,170$89,0000.02%
View complete list of ADMA BIOLOGICS INC shareholders